France: Sanofi makes equity investment and collaboration with Owkin

Global biopharmaceutical company focused on human health, Sanofi, has made an equity investment of US$180m and entered into a new strategic collaboration with Owkin, a French American start-up that specialises in AI and federated learning for medical research. The collaboration is comprised of discovery and development programmes in four exclusive types of cancer, with a total…

You must be a HMI Subscriber to view this content.

Subscribe Now »